Guidelines for treatment of renal injury during cancer chemotherapy 2016

被引：67

作者：

Horie, Shigeo ^{[1
,2
]}

Oya, Mototsugu ^{[3
]}

Nangaku, Masaomi ^{[4
]}

Yasuda, Yoshinari ^{[5
]}

Komatsu, Yasuhiro ^{[6
]}

Yanagita, Motoko ^{[7
]}

Kitagawa, Yuko ^{[8
]}

Kuwano, Hiroyuki ^{[9
]}

Nishiyama, Hiroyuki ^{[10
]}

Ishioka, Chikashi ^{[11
]}

Takaishi, Hiromasa ^{[12
]}

Shimodaira, Hideki ^{[11
]}

Mogi, Akira ^{[9
]}

Ando, Yuichi ^{[13
]}

Matsumoto, Koji ^{[14
]}

Kadowaki, Daisuke ^{[15
]}

Muto, Satoru ^{[1
,2
]}

机构：

[1] Juntendo Univ, Dept Urol, Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan

[2] Juntendo Univ, Dept Adv Informat Genet Dis, Grad Sch Med, Tokyo, Japan

[3] Keio Univ, Dept Urol, Sch Med, Tokyo, Japan

[4] Univ Tokyo, Div Nephrol & Endocrinol, Grad Sch Med, Tokyo, Japan

[5] Nagoya Univ, Dept CKD Initiat Nephrol, Grad Sch Med, Nagoya, Aichi, Japan

[6] St Lukes Int Hosp, Div Nephrol, Dept Med, Tokyo, Japan

[7] Kyoto Univ, Dept Nephrol, Grad Sch Med, Kyoto, Japan

[8] Keio Univ, Dept Surg, Sch Med, Tokyo, Japan

[9] Gunma Univ, Dept Gen Surg Sci, Grad Sch Med, Gunma, Japan

[10] Univ Tsukuba, Dept Urol, Fac Med, Ibaraki, Japan

[11] Tohoku Univ, Dept Clin Oncol, Inst Dev Aging & Canc, Sendai, Miyagi, Japan

[12] Keio Univ, Keio Canc Ctr, Sch Med, Tokyo, Japan

[13] Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi, Japan

[14] Hyogo Canc Ctr, Div Med Oncol, Akashi, Hyogo, Japan

[15] Kumamoto Univ, Fac Pharmaceut Sci, Dept Clin Pharmacol, Kumamoto, Japan

来源：

CLINICAL AND EXPERIMENTAL NEPHROLOGY | 2018年 / 22卷 / 01期

关键词：

ACUTE KIDNEY INJURY; GLOMERULAR-FILTRATION-RATE; HIGH-DOSE CISPLATIN; HEMOLYTIC-UREMIC SYNDROME; BETA-D-GLUCOSAMINIDASE; 2-HOUR OUTPATIENT REGIMEN; ACID-BINDING PROTEIN; TUMOR LYSIS SYNDROME; LONG-TERM EFFICACY; TO 75 MG/M(2);

D O I：

10.1007/s10157-017-1448-z

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：210 / 244

页数：35

共 212 条

[1] Evaluation of glomerular filtration rate estimation by Cockcroft-Gault, Jelliffe, Wright and Modification of Diet in Renal Disease (MDRD) formulae in oncology patients [J].

Ainsworth, N. L. ;

Marshall, A. ;

Hatcher, H. ;

Whitehead, L. ;

Whitfield, G. A. ;

Earl, H. M. .

ANNALS OF ONCOLOGY, 2012, 23 (07) :1845-1853

[2] Biomarkers of AKI: A Review of Mechanistic Relevance and Potential Therapeutic Implications [J].

Alge, Joseph L. ;

Arthur, John M. .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (01) :147-155

[3]

ALSARRAF M, 1982, CANCER TREAT REP, V66, P31

[4]

American Pharmacists Association, 2014, DRUG INF HDB CLIN RE

[5]

Ando M, 2000, CLIN CANCER RES, V6, P4733

[6] Adjustment of creatinine clearance improves accuracy of Calvert's formula for carboplatin dosing [J].

Ando, Y ;

Minami, H ;

Saka, H ;

Ando, M ;

Sakai, S ;

Shimokata, K .

BRITISH JOURNAL OF CANCER, 1997, 76 (08) :1067-1071

[7]

[Anonymous], 2012, NEXAVAR TABLETS 200

[8]

[Anonymous], GUID EV PHARM MED PR

[9]

Arai Yoko, 2008, Nihon Shokakibyo Gakkai Zasshi, V105, P1482

[10] Cisplatin nephrotoxicity [J].

Arany, I ;

Safirstein, RL .

SEMINARS IN NEPHROLOGY, 2003, 23 (05) :460-464

← 1 2 3 4 5 6 7 8 9 10 →